Recommendations for the use of botulinum toxin type A in the management of cerebral palsy.
about
Exploring strategies to prevent post-lobectomy space: transient diaphragmatic paralysis using Botulinum toxin type A (BTX-A).Literature Review and Comparison of Two Statistical Methods to Evaluate the Effect of Botulinum Toxin Treatment on Gait in Children with Cerebral PalsyBotulinum Toxin Treatment for Limb Spasticity in Childhood Cerebral PalsyManagement of upper limb dysfunction in children with cerebral palsy: a systematic reviewUnderstanding the Full Spectrum of Organ Injury Following Intrapartum AsphyxiaReliability and validity of the Upper Limb Physician's Rating Scale in children with cerebral palsyBest clinical practice in botulinum toxin treatment for children with cerebral palsyClinical utility of botulinum toxin in the treatment of cerebral palsy: comprehensive review.Anaesthesia and pain management in cerebral palsy.Recent Advances: OrthopaedicsClassification of gait patterns in spastic hemiplegia and spastic diplegia: a basis for a management algorithm.Spasticity management in the child with spastic quadriplegia.Botulinum toxin type A in the management of equinus in children with cerebral palsy: an evidence-based economic evaluation.Rehabilitation of spasticity and related problems in childhood cerebral palsy.Muscle activation patterns when passively stretching spastic lower limb muscles of children with cerebral palsyDevelopment of treatment concepts for the use of botulinum toxin a in children with cerebral palsy.Injectable neuromuscular blockade in the treatment of spasticity and movement disorders.Botulinum toxin in clinical practiceBotulinum toxin for cerebral palsy; where are we now?Clinical assessment of spasticity in children with cerebral palsy: a critical review of available instruments.Validation of a care and comfort hypertonicity questionnaire.Botulinum toxin treatment of children with cerebral palsy - a short review of different injection techniques.Influence of botulinum toxin therapy on postural control and lower limb intersegmental coordination in children with spastic cerebral palsyBotulinum toxin type A injection for management of upper limb spasticity in children with cerebral palsy: a literature review.The influence of botulinum toxin A injections into the calf muscles on genu recurvatum in children with cerebral palsy.Long-term effect of repeated injections of botulinum toxin in children with cerebral palsy: a prospective study.The effects of botulinum toxin injection frequency on calf muscle growth in young children with spastic cerebral palsy: a 12-month prospective study.Localization of the motor endplate zone in human skeletal muscles of the lower limb: anatomical guidelines for injection with botulinum toxin.The use of botulinum toxin A in children with cerebral palsy, with a focus on the lower limbQuestion 2: is there any long-term benefit from injecting botulinum toxin-A into children with cerebral palsy?Intrinsic properties and functional changes in spastic muscle after application of BTX-A in children with cerebral palsy: systematic review.Best Practices for Intrathecal Baclofen Therapy: Patient Selection.Maternal creatine supplementation during pregnancy prevents acute and long-term deficits in skeletal muscle after birth asphyxia: a study of structure and function of hind limb muscle in the spiny mouse.Management of spasticity and dystonia in children with acquired brain injury with rehabilitation and botulinum toxin A.Therapy service use in children and adolescents with cerebral palsy: An Australian perspective.Adverse drug reactions of botulinum neurotoxin type A in children with cerebral palsy: a pharmaco-epidemiological study in VigiBase.Injection frequency of botulinum toxin A for spastic equinus: a randomized clinical trial.Relation among the gross motor function, manual performance and upper limb functional measures in children with spastic cerebral palsy.Adductor release and chemodenervation in children with cerebral palsy: a pilot study in 16 children.Does botulinum toxin A improve the walking pattern in children with idiopathic toe-walking?
P2860
Q24816864-1BBF6EB2-5348-432B-935A-A586E60301D3Q26749258-160440CC-91A2-40EE-B2AF-CB8FC66AC315Q28074809-76BFFFC3-E860-4A22-97B1-AB9ED7C4E844Q29392890-CEB315E8-5869-469B-AB93-213CD0DE1A75Q30378459-2A75B7EB-DF58-4D0E-A3A4-D8DB20C6F25DQ30611433-748BA858-B53F-4465-9B87-53EE8857663EQ30652125-9663BF7C-BAC1-4F7D-A9BE-58208B6996ACQ32064753-7BBF33C6-AF35-483F-B615-FB366245705CQ33792386-DE238432-3ABB-46F2-B6E6-3C21DDEEDAEBQ33804969-B0D75CFB-4FF8-42A7-947A-6F52D165B510Q34536055-2F2A72F9-060A-4B8D-BDA0-000BFB9B3588Q34536063-3B7BC366-537F-46AB-BE6F-92ADD907849DQ34536094-89BACA64-5B62-4234-BD14-981C0BE34C0CQ35050999-96B6ADD4-0BAE-4F70-85BC-977994E2A1EBQ35126735-02E35E4A-28B6-43D7-997C-F4B3C178A138Q35155959-73DBDCAF-A553-42D9-9753-692E35BB0010Q35292333-4D84B1CA-3E24-47CB-BDBE-E97B9E16618DQ35807826-A1B8E7F4-D28A-46B6-A6C8-A6E36B349027Q35959065-47D0E810-4DB5-4FCD-8558-822E47AEDB87Q36344344-4EA5FC7A-83BC-4111-8A43-9CA838D56659Q36398755-2980CE6D-EDE9-42E1-93F3-17D9908841D2Q36511618-2A07811A-41A5-4E0F-A750-23480936A8BFQ36586751-EEE749E9-E29C-4ADB-8634-78348C571985Q36635231-185E8EEF-78F2-44DD-B3D6-A200B51B8E06Q36912937-849B0F5F-2D94-45C6-A535-5011B154F8C8Q37131063-87884B73-3760-40F2-9DA8-A231076521A0Q37337395-D9321DCB-B8F7-4569-B050-E621E8474634Q37801960-2002BF45-46D4-4B79-9195-7CE83CACAB10Q37883035-A628B5DF-9F7D-44DE-BAA0-DBB15795D32FQ38195735-A0CFDAF1-3894-4998-81A7-7764D9E1B577Q38245465-ECB08BB0-D7A2-404C-B02B-D88EC92E2585Q38902165-17233C78-93EA-4ED6-A333-F2884A0F970CQ39138506-E93C8533-4469-43D5-A18F-DA37F4CA888CQ39303213-8477079E-9708-4EC8-B7A3-D71EA92D5FF7Q40274557-6503AEB6-F3C2-44DE-A560-C4868E3CFD7AQ40561965-F70FFB93-F38F-4E28-8165-934690CD203AQ41109275-8336FEFA-01EF-4AEC-B999-4F1E1DCBD091Q41872743-1061D158-DDB2-44C7-A8FF-DD27F8AE81B8Q42092064-53D75DBE-2B6B-458D-BF0F-367748092C98Q42712811-13D044AB-8472-40D8-97CA-A02541FBBBFB
P2860
Recommendations for the use of botulinum toxin type A in the management of cerebral palsy.
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
Recommendations for the use of ...... management of cerebral palsy.
@ast
Recommendations for the use of ...... management of cerebral palsy.
@en
type
label
Recommendations for the use of ...... management of cerebral palsy.
@ast
Recommendations for the use of ...... management of cerebral palsy.
@en
prefLabel
Recommendations for the use of ...... management of cerebral palsy.
@ast
Recommendations for the use of ...... management of cerebral palsy.
@en
P2093
P50
P1433
P1476
Recommendations for the use of botulinum toxin type A in the management of cerebral palsy
@en
P2093
Autti-Rämö I
Delgado MR
Matthews D
Molenaers G
P356
10.1016/S0966-6362(99)00054-5
P577
2000-02-01T00:00:00Z